Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bitoun

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Medecine Sciences : M/S|November 17, 2023
[The dynamin-2-gene related centronuclear myopathy]Marc Bitoun
Medecine Sciences : M/S|November 28, 2025
[Overlap of neuropathy and myopathy genes: convergence of two entities]Tanya Stojkovic, Marc Bitoun
Journal of Experimental & Clinical Cancer Research : CR|July 23, 2021
A review of Dynamin 2 involvement in cancers highlights a promising therapeutic targetDelphine Trochet, Marc Bitoun
Seminars in Pediatric Neurology|December 17, 2011
Centronuclear myopathiesNorma B Romero, Marc Bitoun
Biology Open|November 22, 2016
Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathyBodvaël Fraysse, Pascale Guicheney, Marc Bitoun
Medecine Sciences : M/S|February 7, 2006
[Mutations in dynamin 2 cause dominant centronuclear myopathy]Marc Bitoun, Norma B Romero, Pascale Guicheney
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 14, 2021
Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathyCamila F Almeida, Marc Bitoun, Mariz Vainzof
Medecine Sciences : M/S|December 20, 2021
[How alternative splicing contributes to clathrin's structural plasticity]Gilles Moulay, Marc Bitoun, Denis Furling, et al.
Current Gene Therapy|August 13, 2015
Therapy for dominant inherited diseases by allele-specific RNA interference: successes and pitfallsDelphine Trochet, Bernard Prudhon, Stéphane Vassilopoulos, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 4, 2010
Dynamin 2 and human diseasesAnne-Cécile Durieux, Bernard Prudhon, Pascale Guicheney, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Medecine Sciences : M/S|November 17, 2023
[The dynamin-2-gene related centronuclear myopathy]Marc Bitoun
Medecine Sciences : M/S|November 28, 2025
[Overlap of neuropathy and myopathy genes: convergence of two entities]Tanya Stojkovic, Marc Bitoun
Journal of Experimental & Clinical Cancer Research : CR|July 23, 2021
A review of Dynamin 2 involvement in cancers highlights a promising therapeutic targetDelphine Trochet, Marc Bitoun
Seminars in Pediatric Neurology|December 17, 2011
Centronuclear myopathiesNorma B Romero, Marc Bitoun
Biology Open|November 22, 2016
Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathyBodvaël Fraysse, Pascale Guicheney, Marc Bitoun
Medecine Sciences : M/S|February 7, 2006
[Mutations in dynamin 2 cause dominant centronuclear myopathy]Marc Bitoun, Norma B Romero, Pascale Guicheney
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 14, 2021
Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathyCamila F Almeida, Marc Bitoun, Mariz Vainzof
Medecine Sciences : M/S|December 20, 2021
[How alternative splicing contributes to clathrin's structural plasticity]Gilles Moulay, Marc Bitoun, Denis Furling, et al.
Current Gene Therapy|August 13, 2015
Therapy for dominant inherited diseases by allele-specific RNA interference: successes and pitfallsDelphine Trochet, Bernard Prudhon, Stéphane Vassilopoulos, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 4, 2010
Dynamin 2 and human diseasesAnne-Cécile Durieux, Bernard Prudhon, Pascale Guicheney, et al.
Pageof 6